Interesting that this issue appears to have been specifically addressed in yesterday's PR.

"Brilacidin’s antiviral potency also appears to extend beyond coronaviruses to other types of viruses, based on independent ongoing laboratory research, further supporting Brilacidin’s broad spectrum antiviral potential.”

I may be wrong, but I don't think we knew anything about B's antiviral properties a year ago.